ALDX
Aldeyra Therapeutics·NASDAQ
--
--(--)
--
--(--)
ALDX fundamentals
Aldeyra Therapeutics (ALDX) released its earnings on Aug 7, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.16 (YoY +42.86%), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-0.16
+42.86%
Report date
Aug 7, 2025
Earnings Call
7:00 AM on Aug 7, 2025
Meeting link.EPS
Actual | -0.34 | -0.25 | -0.23 | -0.29 | -0.25 | -0.28 | -0.27 | -0.27 | -0.29 | -0.3 | -0.25 | -0.22 | -0.27 | -0.15 | -0.08 | -0.14 | -0.28 | -0.25 | -0.27 | -0.17 | -0.16 | |||||||||
Forecast | -0.477 | -0.3514 | -0.2706 | -0.2833 | -0.2636 | -0.2414 | -0.2629 | -0.2835 | -0.315 | -0.3108 | -0.3437 | -0.3132 | -0.2903 | -0.1723 | -0.1105 | -0.1106 | -0.2063 | -0.2471 | -0.2633 | -0.2799 | -0.24 | |||||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +28.72% | +28.86% | +15.00% | -2.36% | +5.16% | -15.99% | -2.70% | +4.76% | +7.94% | +3.47% | +27.26% | +29.76% | +6.99% | +12.94% | +27.60% | -26.58% | -35.72% | -1.17% | -2.54% | +39.26% | +33.33% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | -46 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.00M | 1.20M | 0 | 0 | 0 | -1.00M | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -100.00% | -100.00% | 0.00% | 0.00% | 0.00% | +100.00% | 0.00% |
Earnings Call
You can ask Aime
What is the revenue and EPS growth rate for Aldeyra Therapeutics year over year?What is Aldeyra Therapeutics's gross profit margin?What were the key takeaways from Aldeyra Therapeutics's earnings call?What does Aldeyra Therapeutics do and what are its main business segments?What were the key takeaways from Aldeyra Therapeutics’s earnings call?What guidance did Aldeyra Therapeutics's management provide for the next earnings period?What factors drove the changes in Aldeyra Therapeutics's revenue and profit?What is the market's earnings forecast for Aldeyra Therapeutics next quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
